COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
26 hedge funds and large institutions have $1.83M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
938% more call options, than puts
Call options by funds: $166K | Put options by funds: $16K
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding
Funds holding: 26 → 26 (0)
0% more ownership
Funds ownership: 0.09% → 0.09% (+0%)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
57% less capital invested
Capital invested by funds: $4.22M → $1.83M (-$2.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.04M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$128K |
| 3 |
VF
Virtu Financial
New York
|
+$110K |
| 4 |
Morgan Stanley
New York
|
+$94K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$34.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$540K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$177K |
| 3 |
JGC
J. Goldman & Co
New York
|
-$59K |
| 4 |
Renaissance Technologies
New York
|
-$33.6K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$30K |
CSCI Hedge Fund Activity: Q3 2019 in Review
26 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q3 2019, worth a combined $1.83M — down 57% from $4.22M a quarter earlier.
Fund positioning in CSCI was balanced in Q3 2019: 6 funds opened new positions, 6 closed out, 8 added to existing stakes and 7 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.04M. The largest seller was AJO LP, exiting entirely with an estimated $540K sold.
- 26 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $1.83M of COSCIENS Biopharma Inc. Common Stock stock for Q3 2019, down 57% quarter-over-quarter.
- 6 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q3 2019 and 6 closed out, a net change of 0 holders.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q3 2019 was Armistice Capital, an estimated $1.04M added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q3 2019 was AJO LP, an estimated $540K sold.
Based on aggregated 13F filings for Q3 2019.